• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Authors » Daniel Carlat, MD

Articles by Daniel Carlat, MD

Do Prizes for Abstinence Increase Sobriety in People With Serious Mental Illness?

August 1, 2017
Daniel Carlat, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Daniel Carlat, MD Dr. Carlat has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Although studies have demonstrated the effectiveness of contingency management (CM) for illicit drug use, there’s less evidence for treatment of alcoholism—in part because a standard breathalyzer has a short detection window of 12 hours, meaning patients must only abstain from drinking since the previous night to pass the test.
Read More

NeuroStar’s Latest TMS System: 19 Minutes Is the New 40

July 1, 2017
Daniel Carlat, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Daniel Carlat, MD Dr. Carlat has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
NeuroStar just announced that the FDA has cleared an updated version of its TMS system. Called the NeuroStar Advanced Therapy System, its primary claim to fame is that patients can receive a full TMS treatment in only 19 minutes, as opposed to the 40 minutes required with NeuroStar’s original system.
Read More

Which Are the Most Dangerous Antidepressants?

June 1, 2017
Daniel Carlat, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Daniel Carlat, MD Editor-in-chief, The Carlat Psychiatry Report Dr. Carlat has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.
We often prescribe antidepressants to patients who are suicidal, and unfortunately, some people use these very medications to try to kill themselves. It’s been known for some time that tricyclic antidepressants are among the most toxic in overdose, so we embraced the SSRIs and later medications in part because they are considered to be safer. But how safe are they?
Read More

PANDAS/PANS: A Constellation of Symptoms Searches for a Cause

June 1, 2017
Daniel Carlat, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Daniel Carlat Editor-in-chief, The Carlat Child Psychiatry Report Dr. Carlat has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
PANS and PANDAS--a hitherto normal child suddenly develops severe OCD symptoms. These may include refusing to leave the house, engaging in constant checking and washing rituals, asking repeatedly if the door is locked, making odd facial movements, having full-on tantrums with kicking and screaming, wetting the bed, and being unable to perform in school. “I lost my child overnight” was, and is, a common refrain.
Read More

SSRIs and Bipolar Switching: Evidence of Safety

May 1, 2017
Daniel Carlat, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Daniel Carlat, MD Editor-in-chief, TCPR Dr. Carlat has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Do antidepressants cause bipolar II patients to switch from depression to hypomania? It’s a controversial question, and you’ll find academic psychiatrists who will argue passionately that antidepressants are either safe or dangerous in these patients. The latest study appears to endorse the “safe” camp.
Read More

Pharmacogenetic Testing: An Update

March 1, 2017
Daniel Carlat, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Daniel Carlat, MD Publisher The Carlat Psychiatry Report Dr. Carlat has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Given how many essentially equivalent medications we have to choose from, how great would it be to have a test that tells us which drug to prescribe for which patient? Everybody wants personalized medicine, and in some other specialties, such as oncology, this is becoming a standard part of treatment. In this article, we’ll review some of the basics of pharmacogenetic testing and examine in more detail the commercial genetic tests that are currently available.
Read More

Treating Opioid Use Disorder—A Fact Book (2024)

PDF/eBook and CME Access
February 28, 2017
Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD, have no financial or other interests in any commercial companies pertaining to this educational activity.

This page has links and instructions for downloading your PDF and eBook copies of Treating Opioid Use Disorder—A Fact Book (2024). All versions of this product include access to the 8 CME Post-Test.



Read More

Treating Opioid Use Disorder—A Fact Book (2024)

Print Copy With PDF/eBook and CME Access
February 28, 2017
Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD, have no financial or other interests in any commercial companies pertaining to this educational activity.

This page has links and instructions for downloading your PDF and eBook copies of Treating Opioid Use Disorder—A Fact Book (2024). All versions of this product include access to the 8 CME Post-Test.



Read More
AUDFB1e_Cover.jpg

Treating Alcohol Use Disorder—A Fact Book (2023)

PDF/eBook and CME Access
February 28, 2017
Daniel Carlat, MD, Michael Weaver, MD, and Talia Puzantian, PharmD, BCPP

Daniel Carlat, MD, Michael Weaver, MD, and Talia Puzantian, PharmD, BCPP, have no financial or other interests in any commercial companies pertaining to this educational activity.

This page has links and instructions for downloading your PDF and eBook copies of Treating Alcohol Use Disorder—A Fact Book (2023). All versions of this product include access to the 6 CME Post-Test.



Read More
AUDFB1e_Cover.jpg

Treating Alcohol Use Disorder—A Fact Book (2023)

Print Copy with PDF/eBook and CME Access
February 28, 2017
Daniel Carlat, MD, Michael Weaver, MD, and Talia Puzantian, PharmD, BCPP

Daniel Carlat, MD, Michael Weaver, MD, and Talia Puzantian, PharmD, BCPP, have no financial or other interests in any commercial companies pertaining to this educational activity.

This page has links and instructions for downloading your PDF and eBook copies of Treating Alcohol Use Disorder—A Fact Book (2023). All versions of this product include access to the 6 CME Post-Test.



Read More
Previous 1 2 3 4 5 6 7 8 9 … 19 20 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • MFB8e_SpiralCover.png

    Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

    Updated 2026 prescriber's guide.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2716137939.jpg
    Child Psychiatry

    Living Without Illusions: Psychological Survival in a World of Persistent Hatred

    Today’s episode is one we’ve been sitting with for a long time. We’re talking about how to survive psychologically in a world where hatred is persistent, not abstract,...

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.